Catheter ablation in patients on mechanical circulatory supports for cardiogenic shock
PLOS One · 2025
DOI: 10.1371/journal.pone.0332597 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Milan Dusik und 9 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hosp…. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Catheter Ablation, Heart-Assist Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictvà Ceské Republiky.
Abstract (Originalsprache)
Short-term mechanical circulatory supports (MCS) are used to stabilize patients with severe cardiogenic shock (CS). Catheter ablation may be an option to suppress recurrent arrhythmias preventing MCS weaning. We retrospectively analysed a dedicated registry to identify CS patients who underwent a catheter ablation between January 2020 and August 2024 for treatment resistant and hemodynamically significant arrhythmias while being on the MCS. Patients with supraventricular and ventricular tachycardias (SVT/VT) were analysed separately. Nine patients (8 males, 69 [IQR 60;74] years) were ablated for a refractory VT. Impella CP was used in 6 patients, VA ECMO in 2 patients, and 1 patient was on ECPELLA. Seven patients (78%) were successfully weaned off the MCS after the catheter ablation. 3 patients (33%) died within 30 days. The arrhythmia recurred in 5 patients (56%). Significant complications of MCS were reported in 6 patients (66%). The catheter ablation was complicated in one patient. SVT ablation was performed in 4 patients (3 males, 73 [IQR 67; 78] years, 1x VA ECMO, 2x Impella CP, 1x Impella 5.5). Three patients with atrial fibrillation were treated by a non-selective AV node ablation (pace and ablate strategy). One patient underwent an ablation of focal atrial tachycardia. The MCS was successfully explanted in all patients and no patient died in 30 days. The MCS use was complicated in one patient. Catheter ablation of refractory arrhythmias in CS patients treated by MCS is a safe and feasible approach to facilitate the MCS weaning process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- Institute for Heart Diseases, Wroclaw Medical University, Wrocław, Poland.
ORCID-Profile: Milan Dusik, Stepan Havranek, Ales Linhart, Jan Belohlavek
Förderung
- Ministerstvo Zdravotnictvà Ceské Republiky
Zitieren
APA
Dusik, M., Havranek, S., Rob, D., Simek, J., Valek, M., Fingrova, Z., Boucek, T., Pudil, J., Linhart, A., & Belohlavek, J. (2025). Catheter ablation in patients on mechanical circulatory supports for cardiogenic shock. PLOS One. https://doi.org/10.1371/journal.pone.0332597
Vancouver
Dusik M, Havranek S, Rob D, Simek J, Valek M, Fingrova Z, et al. Catheter ablation in patients on mechanical circulatory supports for cardiogenic shock. PLOS One. 2025. doi:10.1371/journal.pone.0332597
BibTeX
@article{Dusik2025,
author = {Dusik, Milan and Havranek, Stepan and Rob, Daniel and Simek, Jan and Valek, Martin and Fingrova, Zdenka and Boucek, Tomas and Pudil, Jan and Linhart, Ales and Belohlavek, Jan},
title = {Catheter ablation in patients on mechanical circulatory supports for cardiogenic shock},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332597}
}
EUVIMED